₹1,660.80
−1.31%NSE close, 16 Nov 2026
+10.71%
Tatva Chintan Pharma Chem is a small cap company, listed on NSE under the symbol TATVA. At ₹1,660.80 a share, the market values the whole company at ₹3,885 crore.
In FY26, it reported sales of ₹506 crore and a net profit of ₹42 crore, an operating margin of 18.4%. Over the last three years, sales grew 5.3% a year and net profit fell 24.0% a year.
The market values the company at 61.7 times its profit over the last twelve months and 4.77 times its book value; its return on equity is 7.7% and its borrowings are 0.21 times its equity.
Promoters hold 72.02% of the shares. Foreign institutions hold 4.38%, and domestic institutions, mutual funds among them, 3.21%.
Over the past year the share price has risen 14.3%, and it is 21.4% below its 52-week high.
₹ crore. Consolidated figures.
Updated Investor Presentation.
Earnings call scheduled to be held on Monday, 19 October 2026 at 05:00 p.m. (IST) has been cancelled due to unforeseen circumstances.
The financial results for the period ended September 30, 2026.
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 84.2 | 98.3 | 105 | 83.5 | 85.9 | 108 | 117 | 124 | 131 | 134 | 167 | 217 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 73.2 | 82.7 | 92.8 | 77.9 | 78.8 | 98.9 | 99.5 | 101 | 106 | 106 | 135 | 177 |
| Operating profit | 11.0 | 15.6 | 12.6 | 5.6 | 7.1 | 9.0 | 17.3 | 22.2 | 25.5 | 28.1 | 32.3 | 40.7 |
| Operating margin | 13.1% | 15.9% | 12.0% | 6.7% | 8.2% | 8.3% | 14.8% | 18.0% | 19.4% | 21.0% | 19.3% | 18.7% |
| Other income | 1.2 | 4.5 | 1.2 | 0.4 | 0.0 | 0.7 | 1.2 | 1.0 | 1.7 | −0.4 | 2.8 | 1.8 |
| Interest | 0.4 | 0.2 | 0.3 | 0.2 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 1.4 | 2.1 | 2.7 |
| Depreciation | 6.6 | 6.2 | 6.7 | 6.8 | 6.9 | 7.3 | 9.0 | 9.1 | 9.1 | 9.8 | 10.6 | 10.8 |
| Profit before tax | 5.2 | 13.7 | 6.8 | −1.0 | −0.2 | 2.0 | 9.1 | 13.7 | 17.7 | 16.6 | 21.1 | 28.9 |
| Tax | 1.8 | 4.1 | 1.6 | −0.4 | −0.4 | 1.0 | 2.5 | 3.8 | 2.5 | 6.3 | 5.1 | 7.5 |
| Net profit | 3.5 | 9.6 | 5.2 | −0.7 | 0.1 | 1.0 | 6.7 | 9.9 | 15.2 | 10.3 | 16.0 | 21.5 |
| EPS (₹) | 1.48 | 4.11 | 2.23 | -0.29 | 0.06 | 0.44 | 2.84 | 4.24 | 6.49 | 4.41 | 6.83 | 9.17 |
₹ crore, financial years to March.
| Line | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales | 434 | 394 | 383 | 506 |
| Expenses | 325 | 325 | 349 | 413 |
| Operating profit | 108 | 68.2 | 34.2 | 93.2 |
| Operating margin | 25.0% | 17.3% | 8.9% | 18.4% |
| Other income | 8.9 | 7.5 | 2.3 | 3.6 |
| Interest | 4.8 | 6.5 | 1.3 | 2.9 |
| Depreciation | 8.2 | 25.6 | 27.7 | 36.9 |
| Profit before tax | 104 | 43.6 | 7.6 | 57.0 |
| Tax | 8.3 | 13.2 | 1.9 | 15.0 |
| Net profit | 95.9 | 30.4 | 5.7 | 42.1 |
| EPS (₹) | 44.59 | 13.31 | 2.44 | 17.98 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 20.4 | 24.7 | 31.5 | −3.7 |
| From investing | −197 | −65.3 | −116 | −31.3 |
| From financing | 235 | 16.6 | 78.9 | 40.0 |
| Spent on fixed assets | −89.2 | −76.3 | −114 | −30.9 |
| Free cash flow | −68.8 | −51.6 | −82.3 | −34.5 |
Margins, returns, debt, tax and cash.
| Line | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Net margin | 22.1% | 7.7% | 1.5% | 8.3% |
| Operating margin | 25.0% | 17.3% | 8.9% | 18.4% |
| Return on equity | – | 4.1% | 0.8% | 5.4% |
| Return on capital employed | – | 6.7% | 1.1% | 6.6% |
| Return on assets | – | 3.7% | 0.7% | 4.2% |
| Debt to equity | – | 0.02 | 0.05 | 0.15 |
| Interest coverage | 22.60 | 7.70 | 6.90 | 21.00 |
| Debt to assets | – | 0.02 | 0.04 | 0.12 |
| Current ratio | – | 3.74 | 2.76 | 1.64 |
| Quick ratio | – | 1.82 | 1.37 | 0.72 |
| Cash ratio | – | 0.44 | 0.12 | 0.03 |
| Asset turnover | – | 0.48 | 0.46 | 0.50 |
| Fixed asset turnover | – | 0.92 | 0.73 | 0.84 |
| Inventory turnover | – | 1.10 | 1.50 | 1.10 |
| Receivables turnover | – | 5.60 | 4.60 | 4.20 |
| Gross margin | – | 55.7% | 48.0% | 55.6% |
| Cash from operations to profit | 21.0% | – | 432.0% | 75.0% |
| Effective tax rate | 7.9% | 30.3% | 24.7% | 26.2% |
Schedule of meet
Schedule of meet
A copy Srutinizers report of Annual General Meeting held on September 25, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 25, 2026
Schedule of meet
Schedule of meet
Record date for the purpose of Dividend is 11-Sep-2026.
Business Responsibility and Sustainability Report for the FY 2025-26
Notice of Annual General Meeting to be held on September 25, 2026